StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)

Close on Nov 17, 2026Market cap $250.73MP/E –Yield –

USANA Health Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

USANA Health Sciences's operating cash flow for the twelve months ending Jul 4, 2026 was $27.73M, down 56.0% year over year. For fiscal 2025 it was $22.35M, down 63.4% from the year before. Over ten years it grew -14.8% a year on average. The highest annual figure on record is $160.40M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Jan 3, 2026$22.35M-63.4%
FY2024Dec 28, 2024$60.99M-13.7%
FY2023Dec 30, 2023$70.64M-32.0%
FY2022Dec 31, 2022$103.90M-14.3%
FY2021Jan 1, 2022$121.23M-24.4%
FY2020Jan 2, 2021$160.40M+26.6%
FY2019Dec 28, 2019$126.73M-16.7%
FY2018Dec 29, 2018$152.12M+22.9%
FY2017Dec 30, 2017$123.77M-9.6%
FY2016Dec 31, 2016$136.89M+22.8%
FY2015Jan 2, 2016$111.47M+6.0%
FY2014Jan 3, 2015$105.19M+6.4%
FY2013Dec 28, 2013$98.89M+6.6%
FY2012Dec 29, 2012$92.81M+32.4%
FY2011Dec 31, 2011$70.11M+6.1%
FY2010Jan 1, 2011$66.11M+103.6%
FY2009Jan 2, 2010$32.47M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 4, 2026$23.32M+90.9%
Q1 FY2026Apr 4, 2026$9.76M-37.0%
Q4 FY2025Jan 3, 2026-$3.39M-158.6%
Q3 FY2025Sep 27, 2025-$1.96M-106.6%
Q2 FY2025Jun 28, 2025$12.22M+52.9%
Q1 FY2025Mar 29, 2025$15.48M-12.4%
Q4 FY2024Dec 28, 2024$5.79M-77.8%
Q3 FY2024Sep 28, 2024$29.53M+32.8%
Q2 FY2024Jun 29, 2024$7.99M-16.3%
Q1 FY2024Mar 30, 2024$17.68M+37.8%
Q4 FY2023Dec 30, 2023$26.02M-35.7%
Q3 FY2023Sep 30, 2023$22.23M-23.7%
Q2 FY2023Jul 1, 2023$9.55M-34.6%
Q1 FY2023Apr 1, 2023$12.83M-34.9%
Q4 FY2022Dec 31, 2022$40.46M+62.4%
Q3 FY2022Oct 1, 2022$29.13M-22.3%
Q2 FY2022Jul 2, 2022$14.61M-62.7%
Q1 FY2022Apr 2, 2022$19.70M+0.2%
Q4 FY2021Jan 1, 2022$24.92M-48.0%
Q3 FY2021Oct 2, 2021$37.49M-23.6%
Q2 FY2021Jul 3, 2021$39.16M+20.0%
Q1 FY2021Apr 3, 2021$19.66M-36.1%
Q4 FY2020Jan 2, 2021$47.92M-14.0%
Q3 FY2020Sep 26, 2020$49.06M-2.5%
Q2 FY2020Jun 27, 2020$32.64M+115.3%
Q1 FY2020Mar 28, 2020$30.79M+457.6%
Q4 FY2019Dec 28, 2019$55.74M+37.9%
Q3 FY2019Sep 28, 2019$50.31M-7.7%
Q2 FY2019Jun 29, 2019$15.16M-59.8%
Q1 FY2019Mar 30, 2019$5.52M-71.7%
Q4 FY2018Dec 29, 2018$40.43M-26.7%
Q3 FY2018Sep 29, 2018$54.50M+318.0%
Q2 FY2018Jun 30, 2018$37.68M-29.8%
Q1 FY2018Mar 31, 2018$19.52M+926.7%
Q4 FY2017Dec 30, 2017$55.13M-0.0%
Q3 FY2017Sep 30, 2017$13.04M-61.4%
Q2 FY2017Jul 1, 2017$53.70M–
Q1 FY2017Apr 1, 2017$1.90M–
Q4 FY2016Dec 31, 2016$55.15M–
Q3 FY2016Oct 1, 2016$33.76M–

More USANA Health Sciences figures

See a number that looks wrong?